Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01827540
Recruitment Status : Completed
First Posted : April 9, 2013
Last Update Posted : April 9, 2014
ViiV Healthcare
Information provided by (Responsible Party):
Tobira Therapeutics, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 2013
  Study Completion Date : May 2013